Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 6Terminated 2Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 2INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pain 2Uterine Diseases 1Prostatic Neoplasms 1Leiomyoma 1Inflammation 1Hyperuricemia 1Gout 1Dysmenorrhea 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Cardiovascular Diseases 1Breast Neoplasms 1Arthritis 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Naproxen × Clear all
NCT04145518 2025-12-12

MCUP

Endeavor Health

Phase 4 Completed
183 enrolled
Gynecologic

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

NCT03493945 2025-09-30

Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
59 enrolled 20 charts
Genitourinary

Prostatic Neoplasms

NCT02052908 2021-01-25

Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome

National Cancer Institute (NCI)

Phase 1 Completed
81 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed
196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

NCT01712009 2018-01-30

NOLAN

Amgen

Phase 2 Completed
600 enrolled 15 charts
Breast

Breast Neoplasms

NCT00602420 2015-11-09

Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)

University of Rochester

Phase 3 Completed
510 enrolled 17 charts

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡